Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is an experimental small molecule belonging to the class of bipyridines and oligopyridines. Its structure features an indole moiety linked via a chiral ethylene bridge to a pyridine-substituted naphthyridine core. The compound has been referenced in chemical databases as DB07204 and is primarily used in research settings. There is no available information on its clinical use or primary indication. It has been identified as interacting with cAMP-dependent protein kinase catalytic subunit alpha in humans; however, its pharmacological action remains unknown[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (1S)-1-(1H-indol-3-ylmethyl)-2-(2-pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-ethylamine.